We are live on ! Find out more
WSA

Wall Street Associates Portfolio holdings

AUM $151M
1-Year Est. Return 30.3%
This Fund
S&P 500
This Quarter Est. Return
+11.79%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
10 Year Est. Return
AUM
$1.06B
AUM Growth
+$16.2M
Cap. Flow
-$34.7M
Cap. Flow %
-3.28%
Top 10 Hldgs %
16.21%
Holding
377
New
60
Increased
44
Reduced
155
Closed
55

Sector Composition

Rank Sector Weight
1 Healthcare 26.06%
2 Technology 22.46%
3 Consumer Discretionary 14.63%
4 Industrials 9.77%
5 Communication Services 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONTO icon
76
Onto Innovation
ONTO
$15.3B
$5.09M 0.48%
302,500
-3,500
-1% -$59.9K
CIO
77
DELISTED
City Office REIT
CIO
$5.07M 0.48%
398,100
-8,400
-2% -$107K
ARDX icon
78
Ardelyx
ARDX
$997M
$5.06M 0.48%
386,700
-6,100
-2% -$114K
XENT
79
DELISTED
Intersect ENT, Inc
XENT
$4.91M 0.46%
189,900
-7,200
-4% -$165K
MDXG icon
80
MiMedx Group
MDXG
$633M
$4.75M 0.45%
456,450
-238,000
-34% -$2.23M
OIG
81
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$4.7M 0.44%
20,056
-420
-2% -$104K
ENTA icon
82
Enanta Pharmaceuticals
ENTA
$400M
$4.65M 0.44%
151,800
-6,600
-4% -$257K
UCTT
83
Ultra Clean Holdings
UCTT
$3.95B
$4.57M 0.43%
639,500
-6,600
-1% -$58.1K
MHGC
84
DELISTED
Morgans Hotel Group Co.
MHGC
$4.54M 0.43%
586,002
-8,900
-1% -$67.1K
BREW
85
DELISTED
Craft Brew Alliance, Inc.
BREW
$4.49M 0.42%
329,000
+36,067
+12% +$449K
WIFI
86
DELISTED
Boingo Wireless, Inc.
WIFI
$4.48M 0.42%
594,500
-6,100
-1% -$47.3K
ACTA
87
DELISTED
Actua Corp
ACTA
$4.37M 0.41%
282,340
-145,860
-34% -$2.35M
CNCE
88
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$4.33M 0.41%
286,100
-7,700
-3% -$107K
YDLE
89
DELISTED
YODLEE INC COMMON STOCK
YDLE
$4.3M 0.41%
319,200
-4,200
-1% -$49.3K
DARE icon
90
Dare Bioscience
DARE
$21M
$4.28M 0.4%
3,958
FLXN
91
DELISTED
Flexion Therapeutics, Inc.
FLXN
$4.21M 0.4%
187,100
+37,100
+25% +$859K
ARGS
92
DELISTED
Argos Therapeutics, Inc.
ARGS
$4.14M 0.39%
23,245
-510
-2% -$88.7K
SGYP
93
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$4.04M 0.38%
874,600
-20,200
-2% -$65.7K
ADMS
94
DELISTED
Adamas Pharmaceuticals
ADMS
$3.94M 0.37%
225,000
CGI
95
DELISTED
Celadon Group Inc
CGI
$3.88M 0.37%
142,600
-2,300
-2% -$57.2K
OXFD
96
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$3.79M 0.36%
269,100
+46,700
+21% +$636K
AVGR
97
DELISTED
Avinger, Inc. Common Stock
AVGR
$3.74M 0.35%
+3
New +$4.14M
SIEN
98
DELISTED
Sientra, Inc.
SIEN
$3.62M 0.34%
18,840
PFSI icon
99
PennyMac Financial
PFSI
$4.02B
$3.54M 0.33%
208,710
-3,800
-2% -$67.5K
TCON
100
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$3.51M 0.33%
+1,250
New +$3.28M

Similar funds

Wall Street Associates's Q1 2015 Portfolio in Review

As of Q1 2015, Wall Street Associates held 377 positions worth $1.06B, up 1.5% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Wall Street Associates withdrew a net $34.7M in Q1 2015, closing 55 positions and reducing 155 holdings. Its most notable exit was SQUARE 1 FINANCIAL INC COM, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Wall Street Associates opened a new position in El Pollo Loco worth $7.78M.

  • Wall Street Associates's largest Q1 2015 buy was El Pollo Loco: 303,700 shares worth $7.78M.
  • Wall Street Associates added most to Travere Therapeutics in Q1 2015, an estimated $7.25M increase.
  • Wall Street Associates's biggest Q1 2015 reduction was AUSPEX PHARMACEUTICALS INC COM STK (DE), cutting an estimated $7.05M.
  • Wall Street Associates fully exited SQUARE 1 FINANCIAL INC COM in Q1 2015, selling an estimated $11.1M.
  • Wall Street Associates's ten largest holdings make up 16% of its $1.06B portfolio in Q1 2015.
  • Wall Street Associates opened 60 new positions and closed 55 in Q1 2015.
  • Wall Street Associates's portfolio value rose 1.5% quarter-over-quarter to $1.06B.

Based on Wall Street Associates's 13F filing for Q1 2015, filed 14 May 2015.